Condition
T Acute Lymphoblastic Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 4 T Acute Lymphoblastic Leukemia clinical trials that are recruiting, at sites in 3 countries (most in China (2), United States (1), India (1)). By phase: Phase 2 (3), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest T Acute Lymphoblastic Leukemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Daratumumab to clear leftover T‑cell acute lymphoblastic leukemia | Phase 2 | Navi Mumbai, Maharashtra | Recruiting | Jun 15, 2025 |
| Venetoclax plus azacitidine for newly diagnosed ETP-like and myeloid-mutated T-cell ALL | Phase 2 | Suzhou, Jiangsu | Recruiting | Jun 10, 2025 |
| Using CD5 CAR-T Cells to treat relapsed T-Acute Lymphoblastic Leukemia | Early Phase 1 | Hangzhou, Zhejiang | Recruiting | Oct 9, 2024 |
| Combination chemotherapy and nelarabine for T-cell leukemia and lymphoma | Phase 2 | Houston, Texas | Recruiting | Jul 16, 2007 |
All recruiting trials (4)
-
Daratumumab to clear leftover T‑cell acute lymphoblastic leukemia
This trial will try daratumumab given by IV to see if it can clear leftover cancer (MRD) in adults with T‑ALL who remain MRD‑positive after two induction cycles.
-
Venetoclax plus azacitidine for newly diagnosed ETP-like and myeloid-mutated T-cell ALL
This trial will try venetoclax combined with azacitidine as first-line treatment for people aged 14 and older with newly diagnosed ETP-like T-ALL, T-ALL with myeloid mutations, or T/myeloid mixed-phenotype leukemia.
-
Using CD5 CAR-T Cells to treat relapsed T-Acute Lymphoblastic Leukemia
This study is testing a new type of CAR-T cell therapy to see if it can help people with relapsed T-Acute Lymphoblastic Leukemia feel better and improve their chances of recovery.
-
Combination chemotherapy and nelarabine for T-cell leukemia and lymphoma
This study is testing a new combination of chemotherapy drugs and nelarabine to see if it helps people with T-cell leukemia and lymphoma feel better and live longer.
Related topics
Quick answers
How many T Acute Lymphoblastic Leukemia clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), United States (1 trial), India (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.